BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15906753)

  • 1. Circulating ghrelin levels in patients with various upper gastrointestinal diseases.
    Isomoto H; Ueno H; Nishi Y; Yasutake T; Tanaka K; Kawano N; Ohnita K; Mizuta Y; Inoue K; Nakazato M; Kohno S
    Dig Dis Sci; 2005 May; 50(5):833-8. PubMed ID: 15906753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases.
    Nishi Y; Isomoto H; Mukae H; Ishimoto H; Wen CY; Wada A; Ohnita K; Mizuta Y; Murata I; Hirayama T; Nakazato M; Kohno S
    World J Gastroenterol; 2005 Jan; 11(1):99-103. PubMed ID: 15609405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T; Suzuki H; Imaeda H; Hosoda H; Ohara T; Morishita T; Ishii H; Kangawa K; Hibi T
    Hepatogastroenterology; 2005; 52(61):1-4. PubMed ID: 15782980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    BMC Gastroenterol; 2016 Oct; 16(1):119. PubMed ID: 27716077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori.
    Osawa H; Nakazato M; Date Y; Kita H; Ohnishi H; Ueno H; Shiiya T; Satoh K; Ishino Y; Sugano K
    J Clin Endocrinol Metab; 2005 Jan; 90(1):10-6. PubMed ID: 15483107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Helicobacter pylori infection on ghrelin and various neuroendocrine hormones in plasma.
    Isomoto H; Ueno H; Nishi Y; Wen CY; Nakazato M; Kohno S
    World J Gastroenterol; 2005 Mar; 11(11):1644-8. PubMed ID: 15786542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans.
    Isomoto H; Ueno H; Saenko VA; Mondal MS; Nishi Y; Kawano N; Ohnita K; Mizuta Y; Ohtsuru A; Yamashita S; Nakazato M; Kohno S
    Am J Gastroenterol; 2005 Aug; 100(8):1711-20. PubMed ID: 16086706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
    Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
    Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection.
    Gao XY; Kuang HY; Liu XM; Duan P; Yang Y; Ma ZB
    Nutrition; 2009 May; 25(5):506-11. PubMed ID: 19131215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.
    Czesnikiewicz-Guzik M; Loster B; Bielanski W; Guzik TJ; Konturek PC; Zapala J; Konturek SJ
    J Clin Gastroenterol; 2007 Feb; 41(2):145-51. PubMed ID: 17245212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.
    Zub-Pokrowiecka A; Rembiasz K; Konturek SJ; Budzynski A; Konturek PC; Budzynski P
    Med Sci Monit; 2010 Oct; 16(10):CR493-500. PubMed ID: 20885354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
    Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
    Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
    Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.